COVID-19 Vaccines in Patients With Cancer-A Welcome Addition, but There Is Need for Optimization.

Korompoki, Eleni; Gavriatopoulou, Maria; Kontoyiannis, Dimitrios P

Korompoki, Eleni; Gavriatopoulou, Maria; Kontoyiannis, Dimitrios P.

Korompoki E; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Gavriatopoulou M; Department of Clinical Therapeutics, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.
Kontoyiannis DP; Department of Infectious Diseases, Infection Control and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas.

JAMA Oncol ; 7(8): 1113-1114, 2021 08 01.

Article in English | MEDLINE | ID: covidwho-1226174

Subject(s)

COVID-19 Vaccines/immunology; COVID-19/immunology; Neoplasms/immunology; Antibodies, Neutralizing/immunology; Humans; Neoplasms/virology; RNA, Messenger/immunology; SARS-CoV-2/immunology

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 Vaccines / COVID-19 / Neoplasms Topics: Vaccines Limits: Humans Language: English Journal: JAMA Oncol Year: 2021 Document Type: Article Affiliation country: Jamaoncol.2021.1218

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google